ASTH Astrana Health Inc.

  1. Stocks
  2. Healthcare
  3. NASDAQ: ASTH

Price (delayed)

$37.9

Market cap

$2.11B

P/E Ratio

61.13

Dividend/share

N/A

EPS

$0.62

Enterprise value

$2.7B

?
Relative Growth: Rel. Growth: 83
Relative Strength: Rel. Strength: 84
Relative Valuation: Rel. Valuation: 52
Relative Profitability: Rel. Profitability: 38

apollo medical holdings, inc., a physician-centric technology-powered healthcare management company, provides medical care services. the company, leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based ...

Highlights
The revenue has soared by 57% year-on-year and by 11% since the previous quarter
ASTH's gross profit is up by 40% year-on-year and by 10% since the previous quarter
The price to earnings (P/E) is 38% higher than the 5-year quarterly average of 43.0 but 16% lower than the last 4 quarters average of 70.5
The EPS has grown by 35% since the previous quarter but it has declined by 16% year-on-year
The debt has surged by 136% year-on-year
Astrana Health's quick ratio has decreased by 18% YoY and by 3.7% from the previous quarter
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://apollomed.net
Peers: INNV NHC

Key stats

What are the main financial stats of ASTH

ASTH stock price

How has the Astrana Health stock price performed over time
Intraday
3.27%
1 week
-1.12%
1 month
8.35%
1 year
51.24%
YTD
52.76%
QTD
54.57%

Financial performance

How have Astrana Health's revenue and profit performed over time
Revenue
$3.53B
Gross profit
$375.95M
Operating income
$86.47M
Net income
$30.23M
Gross margin
10.7%
Net margin
0.9%
The revenue has soared by 57% year-on-year and by 11% since the previous quarter
The net margin has declined by 44% year-on-year but it has increased by 29% since the previous quarter
ASTH's gross profit is up by 40% year-on-year and by 10% since the previous quarter
Astrana Health's net income has increased by 34% QoQ but it has decreased by 14% YoY

Price vs fundamentals

How does ASTH's price correlate with its fundamentals

Growth

What is Astrana Health's growth rate over time

Valuation

What is Astrana Health stock price valuation
ASTH P/E details
P/E
61.13
P/B
2.63
P/S
0.6
EV/EBIT
25.06
EV/EBITDA
15.93
EV/Sales
0.77
The price to earnings (P/E) is 38% higher than the 5-year quarterly average of 43.0 but 16% lower than the last 4 quarters average of 70.5
The EPS has grown by 35% since the previous quarter but it has declined by 16% year-on-year
ASTH's price to book (P/B) is 42% higher than its last 4 quarters average of 1.8 but 39% lower than its 5-year quarterly average of 4.2
Astrana Health's equity has increased by 7% YoY and by 2.7% from the previous quarter
ASTH's P/S is 71% below its 5-year quarterly average of 2.0 but 16% above its last 4 quarters average of 0.5
The revenue has soared by 57% year-on-year and by 11% since the previous quarter

Efficiency

How efficient is Astrana Health business performance
Astrana Health's return on assets has decreased by 44% YoY but it has increased by 25% QoQ
Astrana Health's return on equity has increased by 34% QoQ but it has decreased by 20% YoY
The company's return on invested capital fell by 29% YoY but it rose by 9% QoQ
The return on sales has declined by 26% year-on-year but it has grown by 11% since the previous quarter

Dividends

What is ASTH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ASTH.

Financial health

How did Astrana Health financials performed over time
The total assets is 32% more than the total liabilities
The company's total liabilities has surged by 119% YoY and by 7% QoQ
The total assets has soared by 77% YoY and by 6% from the previous quarter
The debt is 33% greater than the equity
The debt has surged by 136% year-on-year
The company's debt to equity has surged by 118% YoY but it fell by 3.6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.